De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation

BH Ladle, KP Li, MJ Phillips… - Proceedings of the …, 2016 - National Acad Sciences
BH Ladle, KP Li, MJ Phillips, AB Pucsek, A Haile, JD Powell, EM Jaffee, DA Hildeman
Proceedings of the National Academy of Sciences, 2016National Acad Sciences
DNMT3a is a de novo DNA methyltransferase expressed robustly after T-cell activation that
regulates plasticity of CD4+ T-cell cytokine expression. Here we show that DNMT3a is
critical for directing early CD8+ T-cell effector and memory fate decisions. Whereas effector
function of DNMT3a knockout T cells is normal, they develop more memory precursor and
fewer terminal effector cells in a T-cell intrinsic manner compared with wild-type animals.
Rather than increasing plasticity of differentiated effector CD8+ T cells, loss of DNMT3a …
DNMT3a is a de novo DNA methyltransferase expressed robustly after T-cell activation that regulates plasticity of CD4+ T-cell cytokine expression. Here we show that DNMT3a is critical for directing early CD8+ T-cell effector and memory fate decisions. Whereas effector function of DNMT3a knockout T cells is normal, they develop more memory precursor and fewer terminal effector cells in a T-cell intrinsic manner compared with wild-type animals. Rather than increasing plasticity of differentiated effector CD8+ T cells, loss of DNMT3a biases differentiation of early effector cells into memory precursor cells. This is attributed in part to ineffective repression of Tcf1 expression in knockout T cells, as DNMT3a localizes to the Tcf7 promoter and catalyzes its de novo methylation in early effector WT CD8+ T cells. These data identify DNMT3a as a crucial regulator of CD8+ early effector cell differentiation and effector versus memory fate decisions.
National Acad Sciences